Green Heme-Binding Protein (BLVRB) - A Protein Involved in Various Physiological Processes and Diseases

Target Name: BLVRB

NCBI ID: G645

BLVRB

Green Heme-Binding Protein (BLVRB) - A Protein Involved in Various Physiological Processes and Diseases

Green heme-binding protein (BLVRB) is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and kidneys. It is a protein that plays a critical role in the structure and function of the heme moiety, which is a protein that contains a ferrous ion center that can form a covalent bond with other molecules.

The BLVRB gene was first identified in the late 1990s and has since been shown to be involved in a wide range of physiological processes in the body, including the regulation of inflammation, oxygenation, and blood pressure. It is also expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of BLVRB is its ability to form a covalent bond with other proteins, including heme moieties. This interaction between BLVRB and other proteins is critical for the regulation of a wide range of cellular processes, including the signaling of signaling pathways, the response to stimuli, and the regulation of cellular metabolism.

One of the key functions of BLVRB is its role in the regulation of oxygenation. Oxygenation is a critical aspect of cellular metabolism and is involved in the transfer of electrons from the cell's energy source to its waste products. BLVRB plays a critical role in the regulation of oxygenation by forming a covalent bond with the heme moiety of the protein cytochrome c. This interaction between BLVRB and cytochrome c allows for the regulation of oxygenation and the efficient transfer of electrons from the cell's energy source to its waste products.

Another function of BLVRB is its role in the regulation of inflammation. Inflammation is a critical response of the immune system to the presence of foreign particles or irritants in the body. BLVRB plays a critical role in the regulation of inflammation by forming a covalent bond with the heme moiety of the protein nuclear factor kappa B (NF-kappa-B). This interaction between BLVRB and NF-kappa-B allows for the regulation of inflammation and the suppression of unnecessary immune responses.

In addition to its role in the regulation of oxygenation and inflammation, BLVRB is also involved in the regulation of cellular metabolism and the response to stimuli. It plays a critical role in the regulation of the production and degradation of various cellular organelles, including mitochondria, endoplasmic reticulum, and endosomes. It is also involved in the regulation of cellular signaling pathways, including the regulation of cell growth, cell cycle progression, and apoptosis.

BLVRB is also involved in the regulation of blood pressure, which is critical for maintaining proper cardiovascular function. It plays a critical role in the regulation of smooth muscle contractions and the maintenance of blood pressure.

BLVRB is also expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The high levels of BLVRB expression in these diseases make it an attractive drug target or biomarker for the development of new therapies.

One potential approach to targeting BLVRB is the use of small molecules that can bind to the BLVRB heme moiety. This approach has been shown to be effective in the inhibition of BLVRB-mediated signaling pathways, including the regulation of oxygenation, inflammation, and cellular metabolism.

Another potential approach to targeting BLVRB is the use of antibodies that can bind to the BLVRB protein. This approach has been shown to be effective in the detection and isolation of BLVRB protein, as well as the inhibition of BLVRB-mediated signaling pathways.

In conclusion, BLVRB is a protein that plays a critical role in the regulation of various physiological processes in the body. Its ability to form a covalent bond with other proteins, including heme moieties, makes it an attractive drug target or biomarker for the development of new therapies. Further research is needed to fully understand the role of BLVRB in

Protein Name: Biliverdin Reductase B

Functions: Broad specificity oxidoreductase that catalyzes the NADPH-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone). Contributes to heme catabolism and metabolizes linear tetrapyrroles. Can also reduce the complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH. In the liver, converts biliverdin to bilirubin

The "BLVRB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BLVRB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets